Enhanced antitumor effects of a dendritic cell vaccine transfected with gastric cancer cell total RNA carrying the 4-1BBL gene in vitro

Experimental and Therapeutic Medicine

Volumn 3, Issue 2, 2012, Pages 319-323

  Song, Zhenchuan ^a   Guo, Chenjun ^a   Li, Yong ^a   Tan, Bibo ^a   Fan, Liqiao ^a   Xiao, Jianwei ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

4 1BB ligand; Dendritic cell vaccine; Gene transfection; Murine forestomach carcinoma cell

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CD137 LIGAND; DENDRITIC CELL VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; IN VITRO STUDY; MOUSE; MURINE FORESTOMACH CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH CARCINOMA; TUMOR CELL;

EID: 84855409127     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.394     Document Type: Article

References (22)

1. Lee SW, Park Y, So T, Kwon BS, Cheroutre H, Mittler RS and Croft M: Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells. Nat Immunol 9: 917-926, 2008.
2. Reis e Sousa C: Dendritic cells in a mature age. Nat Rev Immunol 6: 476-483, 2006.
3. Thomas-Kaskel AK and Veelken H: Active immunotherapy of prostate cancer with a focus on dendritic cells. Actas Urol Esp 31: 668-679, 2007.
4. Banchereau J and Palucka AK: Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5: 296-306, 2005.
5. Yu JS, Liu G, Ying H, Yong WH, Black KL and Wheeler CJ: Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res 64: 4973-4979, 2004.
6. Chan T, Sami A, El-Gayed A, Guo X and Xiang J: HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination. Gene Ther 13: 1391-1402, 2006.
7. Huarte E, Cubillos-Ruiz JR, Nesbeth YC, Scarlett UK, Martinez DG, Buckanovich RJ, Benencia F, Stan RV, Keler T, Sarobe P, Sentman CL and Conejo-Garcia JR: Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. Cancer Res 68: 7676-7684, 2008.
8. Moyron-Quiroz JE, Rangel-Moreno J, Hartson L, Kusser K, Tighe MP, Klonowski KD, Lefrançois L, Cauley LS, Harmsen AG, Lund FE and Randall TD: Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 25: 643-654, 2006.
9. Koski GK, Cohen PA, Roses RE, Xu S and Czerniecki BJ: Reengineering dendritic cell-based anti-cancer vaccines. Immunol Rev 222: 256-276, 2008.
10. Jordan KR, McMahan RH, Kemmler CB, Kappler JW and Slansky JE: Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens. Proc Natl Acad Sci USA 107: 4788-4789, 2010.
11. Krause P, Bruckner M, Uermösi C, Singer E, Groettrup M and Legler DF: Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells. Blood 113: 2451-2460, 2009.
12. Yi KH, Nechushtan H, Bowers WJ, Walker GR, Zhang Y, Pham DG, Podack ER, Federoff HJ, Tolba KA and Rosenblatt JD: Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo. Cancer Res 67: 10027-10037, 2007.
13. Kuang Y, Weng X, Liu X, Zhu H, Chen Z, Jiang B and Chen H: Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses. Cancer Lett 293: 254-262, 2010.
14. Shafer-Weaver KA, Watkins SK, Anderson MJ, Draper LJ, Malyguine A, Alvord WG, Greenberg NM and Hurwitz AA: Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells. Cancer Res 69: 6257-6264, 2009.
15. Habib-Agahi M, Phan TT and Searle PF: Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells. Int Immunol 19: 1383-1394, 2007.
16. Radhakrishnan S, Wiehagen KR, Pulko V, Van Keulen V, Faubion WA, Knutson KL and Pease LR: Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells: dependence on TCR:peptide-MHC interaction, ICAM-1, IL-12, and IFN-gamma. J Immunol 178: 3583-3592, 2007.
17. Gautier EL, Huby T, Saint-Charles F, Ouzilleau B, Pirault J, Deswaerte V, Ginhoux F, Miller ER, Witztum JL, Chapman MJ and Lesnik P: Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis. Circulation 119: 2367-2375, 2009.
18. Drakes ML, Czinn SJ and Blanchard TG: Regulation of murine dendritic cell immune responses by Helicobacter felis antigen. Infect Immun 74: 4624-4633, 2006.
19. + T cells. J Immunol 181: 3818-3822, 2008.
20. Sharma RK, Elpek KG, Yolcu ES, Schabowsky RH, Zhao H, Bandura-Morgan L and Shirwan H: Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors. Cancer Res 69: 4319-4326, 2009.
21. Kuroda T, Kitadai Y, Tanaka S, Yang X, Mukaida N, Yoshihara M and Chayama K: Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment. Clin Cancer Res 11: 7629-7636, 2005.
22. Xie SJ, Yan QH, Shan BE, Fu ZX, Meng FJ, Li BD and Cai JH: In vitro experimental study individualised immunotherapy induced by dendritic cells transfected with total RNA of autologous gastric cancer cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 22: 92-95, 2006.